| MÓDULO 1. Introducción al problema del tabaquismo y su tratamiento. Rol de Profesionales de la Salud. |
 Presentación Dr. Eduardo Bianco |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
 Resumen de Módulo 1 |
|
|
Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update |
|
|
International Statistical Classification of Diseases and Related Health Problems (ICD) |
|
|
Smoking Cessation: A Report of the Surgeon General: Full Report: 2020 |
|
|
WHO clinical treatment guideline for tobacco cessation in adults |
|
|
Quitting Smoking Among Adults — United States, 2000–2015 |
|
|
Guidelines for implementation of Article 14 |
|
|
Training package: strengthening health systems for treating tobacco dependence in primary care. Geneva: WHO; 2013 |
|
|
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care |
|
|
Guidelines for implementation of Article 14 |
|
|
| MÓDULO 2. Identificación del usuario |
Presentación Dra. Nelci Becerra |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
MÓDULO 2. Identificación del usuario |
|
|
WHO global report on trends in prevalence of tobacco use 2000–2024 and projections 2025–2030 |
|
|
Stages and processes of self-change of smoking: Toward an integrative model of change. |
|
|
WHO clinical treatment guideline for tobacco cessation in adults |
|
|
Stages and processes of self-change of smoking: Toward an integrative model of change. |
|
|
Quitting Smoking Among Adults — United States, 2000–2015 |
|
|
The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire |
|
|
Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire |
|
|
FACTS ABOUT SECOND-HAND SMOKE WHO |
|
|
Beliefs About the Health Effects of "Thirdhand" Smoke and Home Smoking Bans |
|
|
Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer |
|
|
Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking |
|
|
Recruiting and engaging smokers in treatment in a primary care setting: developing a chronic care model implemented through a modified electronic health record |
|
|
| MÓDULO 3. Intervención breve |
Presentación Dra Luisa Guell 5As |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentación Dra. Laura Jimeno 5Rs |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
MÓDULO 3 Intervención breve |
|
|
Behavioural interventions for smoking cessation: an overview and network meta‐analysis |
|
|
Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings |
|
|
Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance |
|
|
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: WHO; 2024. |
|
|
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: World Health Organization; 2024. |
|
|
Adapting health promotion interventions to meet the needs of ethnic minority groups: mixed-methods evidence synthesis |
|
|
MPOWER WHO |
|
|
Ask Advise Connect: A New Approach to Smoking Treatment Delivery in Healthcare Settings |
|
|
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care |
|
|
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline |
|
|
| MÓDULO 4. Intervenciones motivacionales y conductuales |
Presentación Dra. Luz Helena Alba |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
 Video: "Intervención en paciente motivado" |
|
|
 Video Video: "Intervención incorrecta sobre paciente no motivado" |
|
|
Video: "Intervención correcta sobre paciente no motivado" |
|
|
Video en Ingles: "Intervención integral y recomendada en paciente no motivado" |
|
|
Módulo 4 Intervenciones motivacionales y conductuales |
|
|
Effectiveness of counseling methods in reducing smoking habits for patients with cardiovascular disease: A literature review |
|
|
WHO Clinical Treatment Guideline for Tobacco Cessation in Adults. Geneva: WHO; 2024. |
|
|
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care |
|
|
Smoking Cessation: A Report of the Surgeon General: Full Report: 2020 |
|
|
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline |
|
|
Motivational interviewing for smoking cessation |
|
|
| MÓDULO 5. Introducción al Tratamiento farmacológico |
Presentación Terapia de Reemplazo Nicotínica |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentacion Dra. Lidia Amarales Bupropion |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentación Dr. Carlos Jiménez C Ruiz |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentación Dr. Gustavo Zabert: Vareniclina |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentación Dr. Eduardo Bianco Combinación de fármacos |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
MÓDULO 5. Introducción al Tratamiento farmacológico |
|
|
Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density |
|
|
Gotti C, Clementi FNeuronal nicotinic receptors: from structure to pathology |
|
|
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation |
|
|
Pharmacological interventions for smoking cessation: an overview and network meta‐analysis |
|
|
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation |
|
|
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation |
|
|
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease |
|
|
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial |
|
|
Combination Pharmacotherapy for Stopping Smoking |
|
|
Toll free quitlines |
|
|
Cytisine for smoking cessation |
|
|
| MÓDULO 6. Seguimiento y recaída |
Presentación Dr. Gustavo Zabert |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Presentación Dra. Tania Palacios |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
MÓDULO 6 Seguimiento y recaída |
|
|
Chronic Disease Management for Tobacco Dependence A Randomized, Controlled Trial |
|
|
Outcome criteria in smoking cessation trials: proposal for a common standard |
|
|
Relapse prevention for addictive behaviors |
|
|
The First 7 Days of a Quit Attempt Predicts Relapse |
|
|
| Módulo 7 . Quitlines e intervenciones digitales |
Presentación Dra. Nelci Becerra Intervenciones Digitales |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
MÓDULO 7 Quitlines e intervenciones digitales |
|
|
Toolkit for delivering the 5A’s and 5R’s brief tobacco interventions in primary care |
|
|
WHO clinical treatment guideline for tobacco cessation in adults |
|
|
Mobile phone text messaging and app‐based interventions for smoking cessation |
|
|
Smoking Cessation: A Report of the Surgeon General |
|
|
Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline |
|
|
Telephone counselling for smoking cessation |
|
|
| Módulo 8. Cesación y reducción de daño |
Presentación Dr. Eduardo Bianco. Cesación y reducción de daño |
Mira el video de la presentación, en el que se desarrolla el contenido del módulo.
|
|
Módulo 8. Cesación y reducción de daño |
|
